Astera Labs (NASDAQ:ALAB) Director Jack Lazar Sells 22,500 Shares

Key Points

• Director Jack Lazar of Astera Labs sold 22,500 shares at an average price of $178.42, totaling approximately $4 million, which decreased his ownership stake by 18.77%.
• Astera Labs reported earnings of $0.44 EPS for the last quarter, surpassing analyst expectations by $0.11, with a revenue increase of 149.5% year-over-year.
• The company's recent stock performance shows a trading price of $189.15 and an average target price set by analysts at $129.13.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) Director Jack Lazar sold 22,500 shares of the stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $178.42, for a total value of $4,014,450.00. Following the completion of the sale, the director directly owned 97,351 shares in the company, valued at $17,369,365.42. This represents a 18.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Astera Labs Stock Performance

ALAB traded up $9.95 during trading on Thursday, reaching $189.15. The company had a trading volume of 4,727,064 shares, compared to its average volume of 6,013,467. The firm's 50-day simple moving average is $128.86 and its 200 day simple moving average is $94.43. Astera Labs, Inc. has a 12-month low of $36.85 and a 12-month high of $199.47. The company has a market cap of $31.44 billion, a price-to-earnings ratio of 338.11, a PEG ratio of 4.54 and a beta of 1.39.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. The business had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm's revenue for the quarter was up 149.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Great Valley Advisor Group Inc. grew its stake in shares of Astera Labs by 2.2% in the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company's stock worth $372,000 after buying an additional 90 shares during the last quarter. Straight Path Wealth Management grew its position in shares of Astera Labs by 1.5% during the second quarter. Straight Path Wealth Management now owns 6,850 shares of the company's stock valued at $619,000 after purchasing an additional 100 shares in the last quarter. First Horizon Advisors Inc. increased its holdings in shares of Astera Labs by 12.4% in the second quarter. First Horizon Advisors Inc. now owns 982 shares of the company's stock worth $89,000 after purchasing an additional 108 shares during the last quarter. Advisors Asset Management Inc. grew its position in Astera Labs by 68.6% in the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company's stock worth $43,000 after acquiring an additional 194 shares in the last quarter. Finally, Hoey Investments Inc. boosted its position in shares of Astera Labs by 4.2% during the first quarter. Hoey Investments Inc. now owns 5,000 shares of the company's stock valued at $298,000 after buying an additional 200 shares during the period. Institutional investors own 60.47% of the company's stock.

Analysts Set New Price Targets

ALAB has been the subject of a number of recent research reports. Stifel Nicolaus set a $145.00 target price on Astera Labs and gave the stock a "buy" rating in a research report on Monday, August 4th. Wall Street Zen upgraded Astera Labs from a "hold" rating to a "buy" rating in a research note on Saturday, August 16th. Roth Capital set a $100.00 price target on Astera Labs and gave the stock a "buy" rating in a report on Wednesday, May 7th. William Blair assumed coverage on Astera Labs in a research report on Thursday, May 22nd. They set an "outperform" rating for the company. Finally, Susquehanna upped their target price on Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a research report on Thursday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $129.13.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.